COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST
Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed. L'invention conce...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
10.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux. |
---|---|
AbstractList | Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed.
L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux. |
Author | OSTOVIC, Drazen KARABORNI, Sami LIU, Jiwen |
Author_xml | – fullname: OSTOVIC, Drazen – fullname: KARABORNI, Sami – fullname: LIU, Jiwen |
BookMark | eNrjYmDJy89L5WQwcvZ3DooMDnH0CVbwd1Nw9FNwdHH18w_29HNVcDRyUghydXYNCPEPAsqEOLr7-3kGh_AwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvhwfyMDIyMDU0NTC0tHQ2PiVAEAAvcpXQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | CO-CRISTAUX D'UN ANTAGONISTE DU RÉCEPTEUR DE L'ADÉNOSINE A2B |
ExternalDocumentID | WO2022051589A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2022051589A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:02:09 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2022051589A13 |
Notes | Application Number: WO2021US49011 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=WO&NR=2022051589A1 |
ParticipantIDs | epo_espacenet_WO2022051589A1 |
PublicationCentury | 2000 |
PublicationDate | 20220310 |
PublicationDateYYYYMMDD | 2022-03-10 |
PublicationDate_xml | – month: 03 year: 2022 text: 20220310 day: 10 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | TEON THERAPEUTICS, INC |
RelatedCompanies_xml | – name: TEON THERAPEUTICS, INC |
Score | 3.3840482 |
Snippet | Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&locale=&CC=WO&NR=2022051589A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s06hvOjVOpyHR8EYcUGA8LAYKOI2jBFDn01K-EhPDFofx3_dApnvaW9tLru0l1-uvvQ-AG7wkcz01iWRwdSgRk2uSmWiJpBJe5EWuaZlcBzhPfX3yTB5n2qwDH-tYmCZP6HeTHBE1KkV9r5rzevn_iOU0vpWr2-QdhxZ3Xjx2xBYdK0qd6VJ07LEbMIdRkVLEbaIf_tLQdo9MC7HSDl6kjVof3Be7jktZbhoV7xB2A-RXVkfQycse7NN17bUe7E3bL29sttq3OgaFMhq-RbH1FAnMEyxfQDH6rC6cIViKLYQudYOYhUiJrXvmP0TxCVx7bkwnEk4-_9vr_JVtrlQ9hW65KPMzEDRVHw2zRFYzsyBKgkiJZ1wuDARoKc9U0ofBNk7n28kXcFB3pcZRbQDd6vMrv0RrWyVXjZB-AKamfW0 |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s0zjfdGr8mEqi4Y24QdnGw2JYAZlulEDV-bSUAYmJYYvD-O97INM97a3pJdf2kuvdr70PgFt0kkV3bhClJ7S2QgyhK0akR4pGRJqkia7HnSLBeeJ13WfyONWnNfhY58KUdUK_y-KIqFFz1Pe8vK-X_49YVhlbubqL3nFqce_wgSVX6FhVi0qXsjUc2D6zGJUpRdwme8EvDW133zARK-2gk90r9MF-GRZ5KctNo-IcwK6P_LL8EGpJ1oQGXfdea8LepPryxmGlfasjUCmjwVvIzXEoMUcyPQnF6LGicYZkqkMpsKntcxYghZsPzBuF_BhuHJtTV8HFZ39nnb2yzZ1qJ1DPFllyCpKudfvtOOposZESNUKkJGLRSXsI0OYi1sgZtLZxOt9OvoaGyyfj2XjkPV3AfkFSyqC1FtTzz6_kEi1vHl2VAvsBtD-AYA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COCRYSTALS+OF+AN+ADENOSINE+A2B+RECEPTOR+ANTAGONIST&rft.inventor=OSTOVIC%2C+Drazen&rft.inventor=KARABORNI%2C+Sami&rft.inventor=LIU%2C+Jiwen&rft.date=2022-03-10&rft.externalDBID=A1&rft.externalDocID=WO2022051589A1 |